Biomaterials to gene delivery.
暂无分享,去创建一个
[1] T. Okano,et al. Heparin immobilization onto segmented polyurethane-urea surfaces--effect of hydrophilic spacers. , 1988, Journal of biomedical materials research.
[2] S. W. Kim,et al. Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. , 2008, Bioconjugate chemistry.
[3] Teruo Okano,et al. PGE1-Heparin conjugate releasing polymers , 1985 .
[4] S. W. Kim,et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] S. W. Kim,et al. Development of a safe gene delivery system using biodegradable polymer, poly[α-(4-aminobutyl)-L-glycolic acid] [19] , 2000 .
[6] S. W. Kim,et al. Folate-PEG-Folate-Graft-Polyethylenimine-Based Gene Delivery , 2001, Journal of drug targeting.
[7] T. Okano,et al. A new thermo-sensitive hydrogel: Interpenetrating polymer networks from N-acryloylpyrrolidine and poly(oxyethylene) , 1988 .
[8] Steven Edward Kern,et al. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] S. W. Kim,et al. The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. , 2010, Biomaterials.
[10] S. W. Kim,et al. A self-regulating insulin delivery system. II. In vivo characteristics of a synthetic glycosylated insulin , 1989 .
[11] J. Feijen,et al. Drug-Coupled Poly(Amino Acids) as Polymeric Prodrugs , 1988 .
[12] F. Liu,et al. Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[13] T. Park,et al. Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[14] S. W. Kim,et al. A self-regulating insulin delivery system. I. Characterization of a synthetic glycosylated insulin derivative , 1989 .
[15] F. Liu,et al. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. , 1999, Human gene therapy.
[16] S. W. Kim,et al. Self-regulated glycosylated insulin delivery , 1990 .
[17] S. W. Kim,et al. Self-regulating insulin delivery systems: III. In vivo studies , 1985 .
[18] S. W. Kim,et al. Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. , 2008, Biomaterials.
[19] D. Bull,et al. Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct , 2009, Gene Therapy.
[20] A. Maruyama,et al. A new non-viral DNA delivery vector: the terplex system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[21] S. W. Kim,et al. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice , 2000, Gene Therapy.
[22] J. Andrade,et al. Platelet adhesion to polymer surfaces. , 1974, Transactions - American Society for Artificial Internal Organs.
[23] S. W. Kim,et al. An angiogenic, endothelial-cell-targeted polymeric gene carrier. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] S. W. Kim,et al. Adsorption of proteins onto hydrophobic polymer surfaces: adsorption isotherms and kinetics. , 1974, Journal of biomedical materials research.
[25] S. W. Kim,et al. Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. , 2011, Biomaterials.
[26] D. Gregonis,et al. CONTROLLED RELEASE OF PROGESTINS FROM poly(α-AMINO ACID) CARRIERS , 1980 .
[27] S. W. Kim,et al. Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. , 2010, Biomaterials.
[28] J. Feijen,et al. Coupling of Naltrexone to Biodegradable Poly(α-Amino Acids) , 1987, Pharmaceutical Research.
[29] Sung Wan Kim,et al. Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.
[30] S. W. Kim,et al. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[31] S. W. Kim,et al. Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] R. Mahato,et al. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] S. W. Kim,et al. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[34] J. Feijen,et al. Poly(dimethylsiloxane)-poly(ethylene oxide)-heparin block copolymers. I. Synthesis and characterization. , 1988, Journal of biomedical materials research.
[35] S. W. Kim,et al. GLP-1 gene delivery for the treatment of type 2 diabetes. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[36] Y. Bae,et al. Electrically credible polymer gel for controlled release of drugs , 1991, Nature.
[37] J. Feijen,et al. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. , 2006, Bioconjugate chemistry.
[38] T. Okano,et al. Thermo-sensitive polymers as on-off switches for drug release , 1987 .